Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

SNY 49.44 -0.80 (-1.59%)
price chart
French Transaction Tax Misses Mark as Speculators Find Loopholes
On Nov. 1, the state started collecting the levy on the purchase of 109 French stocks with market values of more than 1 billion euros ($1.2 billion), including Sanofi SA and Vivendi SA. While the ... How the tax will be imposed on ADRs wasn't ...
Related articles »  
Buffett's Significant Changes To Berkshire Hathaway Stock Holdings
Sanofi-Aventis (NYSE: SNY) was 4.06 million shares; SAME AS before. Torchmark Corp. (NYSE: TMK) was more than 4.2 million, SAME AS last quarter after having been raised in a prior quarter.
Related articles »  
China Drug Market to Boom � Diabetes Alone a $3.2 Billion Business by 2016
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc. We were unable to load Disqus.
Related articles »  
The Supreme Court confirms when the limitation period starts to run in follow ...
In BCL Old Co Limited and Others v. BASF plc and Others [2012] UKSC 45, the Supreme Court, in its first competition damages case, confirmed that the two-year limitation period to bring a follow-on damages claim begins to run from the date on which the ...
Biotech Stocks to Buy Now
(NYSE: BMY), Sanofi SA (ADR NYSE: SNY) and GlaxoSmithKline plc (ADR NYSE: GSK). �ARIAD Pharmaceuticals, Inc.'s (Nasdaq: ARIA) Ridaforolimus is being studied in multiple clinical trials in patients with metastatic sarcomas, breast cancer, endometrial ...
Related articles »